Covista Inc. CVSA
120.75
(3.41)
(2.75%)
as of 25 Sep
- Market cap
- $4.2B
- P/E
- 16.8×
Follow CVSA
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
22.45 | 14.80 | 17.57 | 17.39 |
P/S ratio |
3.04 | 1.96 | 2.07 | 2.24 | |
P/FCF ratio |
16.87 | 9.85 | 11.50 | 11.12 | |
P/Operating CF |
42.72 | 124.28 | 21.22 | 35.24 | |
P/B ratio |
3.83 | 2.68 | 2.90 | 3.02 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
3.22 | 2.21 | 2.25 | 2.37 | |
EV/EBITDA |
13.17 | 9.15 | 9.45 | 9.75 | |
EV/Operating CF |
15.56 | 9.76 | 10.59 | 9.83 | |
EV/FCF |
17.85 | 11.13 | 12.52 | 11.77 | |
Quick Ratio |
0.80 | 0.50 | 0.56 | 0.97 | |
Current Ratio |
0.98 | 0.68 | 0.70 | 1.09 | |
Net Debt/EBITDA |
2.68 | 3.34 | 3.01 | 2.18 | |
Debt/Assets |
19.29% | 19.29% | 18.25% | 22.00% | |
Debt/Equity |
0.38 | 0.37 | 0.37 | 0.46 | |
Asset Turnover |
0.64 | 0.71 | 0.69 | 0.68 | |
Operating CF/Net income |
2.11 | 0.39 | 4.47 | 1.73 | |
Capex/Depreciation |
(0.75) | (0.65) | (0.80) | (1.24) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
38.01% | 36.31% | 37.80% | 37.51% | |
Intangible Assets out of Total Assets |
0.60 | 0.66 | 0.63 | 0.57 | |
Share Based Compensation of Revenue |
1.79% | 2.63% | 1.97% | 2.02% | |
Graham Net Nets |
(0.15) | (0.25) | (0.25) | (0.21) | |
Graham Number |
79.05 | 77.91 | 76.64 | 81.59 | |
Earnings Yield |
4.45% | 6.76% | 5.69% | 5.75% | |
Free Cash Flow Yield |
5.93% | 10.15% | 8.70% | 8.99% | |
Revenue per Share |
12.80 | 14.09 | 14.21 | 14.31 | |
Operating CF per Share |
3.62 | 0.83 | 5.43 | 3.54 | |
Capex per Share |
(0.44) | (0.41) | (0.59) | (0.77) | |
Free Cash Flow per Share |
3.17 | 0.42 | 4.84 | 2.77 | |
Cash per Share |
7.37 | 1.64 | 4.34 | 11.64 | |
Shareholders Equity per Share |
40.37 | 38.59 | 39.79 | 41.27 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
40.37 | 38.59 | 39.79 | 41.27 | |
Free Cash Flow |
114.53 | 15.12 | 165.93 | 97.15 | |
Working Capital |
(9.40) | (139.90) | (176.69) | 55.62 | |
Capital Expenditures |
(16.02) | (14.62) | (20.23) | (26.81) | |
Net Current Asset Value |
(842.62) | (932.93) | (969.57) | (914.08) | |
EV/EBIT |
16.54 | 11.48 | 11.79 | 12.06 | |
Capex to Sales |
0.03 | 0.03 | 0.04 | 0.05 | |
Net Profit Margin |
13.38% | 15.17% | 8.55% | 14.30% | |
Price to Operating Income |
15.63 | 10.15 | 10.83 | 11.40 | |
| Other line items | |||||
Average Receivables |
183.17 | 154.91 | 169.45 | 157.88 | |
Average Payables |
98.00 | 85.01 | 97.99 | 114.89 | |
Average Assets |
2,842.59 | 2,668.83 | 2,763.59 | 2,882.53 | |
Average Common Equity |
1,423.79 | 1,408.85 | 1,398.41 | 1,439.91 |
Columns are period end dates